0.7(top 50%)
impact factor
368(top 50%)
papers
3.2K(top 20%)
citations
29(top 20%)
h-index
0.7(top 50%)
impact factor
422
all documents
3.5K
doc citations
42(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Bladder Cancer Molecular Taxonomy: Summary from a Consensus MeetingBladder Cancer2016184
2A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder CancerBladder Cancer201679
3Clarification of Bladder Cancer Disease States Following Treatment of Patients with Intravesical BCGBladder Cancer201575
4Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)Bladder Cancer201673
5Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder CancerBladder Cancer201569
6Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder CancerBladder Cancer201760
7Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell LinesBladder Cancer201858
8Micropapillary Bladder Cancer: Insights from the National Cancer DatabaseBladder Cancer201656
9The BCG ShortageBladder Cancer201755
10Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer PatientsBladder Cancer201855
11Real-World Effectiveness of Chemotherapy in Elderly Patients With Metastatic Bladder Cancer in the United StatesBladder Cancer201855
12The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New AnalysisBladder Cancer201646
13Systematic Review and Meta-Analysis on the Impact of Hexaminolevulinate- Versus White-Light Guided Transurethral Bladder Tumor Resection on Progression in Non-Muscle Invasive Bladder CancerBladder Cancer201645
14Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and ProgressionBladder Cancer201644
15Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery ProtocolBladder Cancer201743
16Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder CancerBladder Cancer201741
17Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder CancerBladder Cancer201841
18Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life InstrumentsBladder Cancer201640
19Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T MutationBladder Cancer201840
20Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder CancerBladder Cancer201739
21The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder CancerBladder Cancer201638
22The New Immortalized Uroepithelial Cell Line HBLAK Contains Defined Genetic Aberrations Typical of Early Stage Urothelial TumorsBladder Cancer201634
23A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial CarcinomaBladder Cancer201634
24Systematic Review: Targeting HER2 in Bladder CancerBladder Cancer201934
25Body Mass Index, Diet-Related Factors, and Bladder Cancer Prognosis: A Systematic Review and Meta-AnalysisBladder Cancer201833
26Urinary Biomarkers in the Evaluation of Primary Hematuria: A Systematic Review and Meta-AnalysisBladder Cancer201833
27Bladder Cancer Genetic Susceptibility. A Systematic ReviewBladder Cancer201833
28Bacillus Calmette-Guérin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive DiseaseBladder Cancer201632
29Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical CystectomyBladder Cancer201631
30Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerBladder Cancer201630
31Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-AnalysisBladder Cancer201730
32Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?Bladder Cancer201730
33Pursuing Quality in the Application of Bladder Cancer Quality of Life ResearchBladder Cancer201629
34Inhibiting Immune Checkpoints for the Treatment of Bladder CancerBladder Cancer201629
35Antibody-Drug Conjugates in Bladder CancerBladder Cancer201829
36Systematic Review: An Update on the Spectrum of Urological Malignancies in Lynch SyndromeBladder Cancer201828
37Image-Guided Transurethral Resection of Bladder Tumors – Current Practice and Future OutlooksBladder Cancer201727
38Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging TherapiesBladder Cancer201827
39Early Complications and Mortality following Radical Cystectomy: Associations with Malnutrition and ObesityBladder Cancer201826
40Transversus Abdominis Plane Blockade as Part of a Multimodal Postoperative Analgesia Plan in Patients Undergoing Radical CystectomyBladder Cancer201826
41Systematic Review: Depression and Anxiety Prevalence in Bladder Cancer PatientsBladder Cancer201826
42Treatment Decision Making in Patients with Bladder CancerBladder Cancer201525
43Limited Funds for Bladder Cancer Research and What Can We Do About ItBladder Cancer201625
44Bladder Preservation for Muscle Invasive Bladder CancerBladder Cancer201625
45Circulating Biomarkers in Bladder CancerBladder Cancer201625
46Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment ResponseBladder Cancer201624
47Elevated Derived Neutrophil-to-Lymphocyte Ratio Corresponds With Poor Outcome in Patients Undergoing Pre-Operative Chemotherapy in Muscle-Invasive Bladder CancerBladder Cancer201624
48Efficacy of Mycobacterium Phlei Cell Wall-Nucleic Acid Complex (MCNA) in BCG-Unresponsive PatientsBladder Cancer201724
49Ten Years of Proteomics in Bladder Cancer: Progress and Future DirectionsBladder Cancer201724
50The Role of PD-L1 Expression and Intratumoral Lymphocytes in Response to Perioperative Chemotherapy for Urothelial CarcinomaBladder Cancer201623